Toho Holdings Rejects Shareholder Demand to Sue Directors Over Bid-Rigging Scandal

Toho Holdings Co., Ltd. ( (JP:8129) ) has issued an announcement.

Toho Holdings announced that its Audit and Supervisory Committee has unanimously decided not to file a liability lawsuit against 16 current and former directors over bid-rigging cases at subsidiaries Toho Pharmaceutical and Kyushutoho. The shareholder 3D WH OPPORTUNITY MASTER OF-3D WH OPPORTUNITY HOLDINGS had demanded directors be sued for more than ¥3.8 billion, alleging failures in preventing antitrust violations and establishing adequate internal controls.

After appointing an independent law firm to assist, the committee said it found no evidence that the directors were actively involved in or aware of the bid rigging, nor that they should reasonably have known about it under the compliance framework in place at the time. On that basis, it concluded there was no breach of duty requiring a liability suit, while emphasizing that Toho remains committed to strengthening governance and will present broader measures to enhance corporate value following a strategic review due for announcement in April 2026.

The most recent analyst rating on (JP:8129) stock is a Hold with a Yen5068.00 price target. To see the full list of analyst forecasts on Toho Holdings Co., Ltd. stock, see the JP:8129 Stock Forecast page.

More about Toho Holdings Co., Ltd.

Toho Holdings Co., Ltd. is a Japan-based pharmaceutical wholesaler that operates through subsidiaries such as Toho Pharmaceutical and Kyushutoho. The group focuses on the distribution of pharmaceuticals and related products to medical institutions, operating within a tightly regulated market where compliance with antitrust and fair trade rules is a critical aspect of its business environment.

Average Trading Volume: 132,580

Technical Sentiment Signal: Strong Buy

Current Market Cap: Yen310.2B

For an in-depth examination of 8129 stock, go to TipRanks’ Overview page.